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In this case report, we present a paternal transmission of a classic 3 Mb 22q11.2 deletion syndrome
(22q11.2 DS) in a 3 generation family. In this family a young girl, her father, her uncle and her grandfather
were diagnosed with this disorder. All carriers showed phenotypic expression, there were no unaffected
siblings in the second or third generation. Presenting symptoms in the patient in first generation
(grandfather) were psoriatic arthritis, thrombocytopenia and a right aortic arch. There was no intellectual
disability. The second generation uncle was known with a severe intellectual disability, mild facial
characteristics, a septal defect and a clubfoot, whereas the second generation father had a tetralogy of
Fallot, no intellectual disability and minimal facial characteristics. The third generation daughter had a
moderate intellectual disability, hypernasal speech, triphalangeal thumb, severe speech and language
development delay, pronounced facial characteristics and a diagnosis of ADHD. It was notable that the
expression in the two brothers of the second generation gives two very different clinical phenotypes
with a severe intellectual disability in the oldest brother. This report describes a pronounced clinical
variability in a 3 generation familial 22q11.2 deletion with paternal transmission. We can assume that
several mechanisms play an important role in the heterogeneity and part of the answer should be found
in the genetic background underlying the 22q11.2 deletion. In addition in this family the neuropsychi-
atric phenotype and intellectual disability seem to be associated with a lower level of social and occu-
pational functioning while a congenital heart disease does not. This clinical report illustrates that a
detailed description of these patients can be very informative and still increase the knowledge on this
heterogonous syndrome. For the clinicians working with these patients it emphasizes the need for a
multidisciplinary approach that takes into account the individual needs.
 2015 Published by Elsevier Masson SAS.100
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1111. Introduction
The 22q11.2 deletion syndrome (22q11.2DS) is a phenotypically
heterogenous syndrome caused by a hemizygous microdeletion at
the q11.2 region of chromosome 22. Next to being the most com-
monmicrodeletion syndromewith an estimated overall prevalence
of 1 in 4000 live births [Oskarsdóttir et al., 2004], it is also
characterized by a higher phenotypic variability compared to
other micodeletion syndromes f.e. Williams or PradereWilliUniversity Hospitals Leuven,
n, Belgium.
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.
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n Journal of Medical Geneticsyndrome. The phenotypic expression of this deletion is complex
and varies ranging from facial dysmorphism, congenital heart
defects, hypocalcemia, palate defects, immunodeficiency,
neurodevelopmental delays and learning difficulties to psychiatric
disorders [McDonald-McGinn and Sullivan, 2011]. More than 180
clinical features, both physical and behavioral, have been
described. Several mechanisms have been proposed to be
responsible for this phenotypic variability. Decreased gene dosage
of multiple genes is believed to be involved in phenotypic
expression [Meechan et al., 2011]. The size of the 22q11.2
deletion is in approximately 87% of patients a deletion of about
3 Mb containing about 60 genes, and around 8% carry a smaller
deletion of about 1.5 Mb containing about 35 genes [ Shaikh
et al., 2000]. Until now, there is no correlation found between the117
118
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EJMG3017_proof ■ 6 February 2015 ■ 2/5size of the deletion and phenotypic expression [Michaelovsky et al.,
2012], though it is accepted that deletion of the 1.5 Mb region can
induce a full-scale clinical picture and therefore the 1.5 Mb region is
called the critical deletion region. Identification of the micro-
deletion can be performed through different molecular techniques.
Until several years ago, fluorescence in situ hybridization (FISH)
and MLPA were commonly used to ascertain a diagnosis after
clinical suspicion of a 22q11 DS. More recently, chromosomal
microarray technologies (array CGH) are implemented to identify
the 22q11.2 deletion in a proband, having the advantage of being
able to screen the entire genome for submicroscopic rearrange-
ments. In more than 90% of cases, the deletion occurs de novo, in
the remaining 10% the deletion is inherited from the affected parent
(familial deletion) [McDonald-McGinn et al., 2001]. The inheritance
pattern is autosomal dominant. In this case report, we present for
the first time a 3 generation family with a paternal transmission
of a 22q11.2 DS.83
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1062. Case presentation
We present a three generation pedigree, with four individuals
carrying a 22q11.2 DS. In all affected individuals, paternal trans-
mission of the deletion was observed. The index patient, II.1 (see
Fig. 1), is an adult man living in a residential setting for people with
moderate to severe intellectual disability (ID) In search for a
possible explanation for his behavioral problems, ID and facial
dysmorphism, a clinical genetic evaluation was requested. Array
CGH revealed the typical w3 Mb microdeletion at the 22q11.2
region (Fig. 2).
Around the same time, the daughter of the youngest brother
(III.1) was evaluated at our department, at age 4 years. She was
referred because of distinct facial characteristics and presence of a
pronounced developmental delay in several domains such as fine
and gross motor skills, speech, language and cognition. FISH
confirmed the clinical suspicion of a 22q11.2 DS.
Subsequent family screening using FISH revealed that both fa-
ther (II.3) and grandfather (I.1) carried the microdeletion at
22q11.2. There was a miscarriage of the second child (II.2, also a
boy) at 6 months of pregnancy, of unknown cause and there was no
further genetic information available.Fig. 1. Pedigree of the 3-generation family in this report. Blue colored boxes are the
individuals with a 22q11.2DS. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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On clinical investigation I.1 would not have been suspected of
having a 22q11.2 deletion, except for some very mild facial char-
acteristics. Compared to the other family members with 22q11.2DS,
he has a limited medical history encompassing regular follow-ups
for his psoriatic arthritis, a right aortic arch and a diagnosis of
mild thrombocytopenia (136,000/microL in 2006; 139,000/microL
in 2013). His youngest son II.3 has an extensive cardiac history with
corrective cardiac surgery at an early age for a Tetralogy of Fallot
and several cardiac surgical procedures later in life. This included a
Bentall procedure because of an ascending aortic aneurysm with a
dilated aortic root and aortic insufficiency, and a pacemaker to treat
a third-degree atrioventricular block. The oldest brother II.1 also
had a septal defect, mild scoliosis and mild thrombocytopenia. The
granddaughter III.1 had a triphalangeal thumb, pointed fingers and
pronounced facial features including plagiocephaly, a pronounced
nasal bridge, deep-set eyes, small ears and a small mouth with a
short philtrum. She was hospitalized at several occasions because
of recurrent bronchopneumonia. A severe speech delay with very
hypernasal speech was present although video faryngography
excluded velopharyngeal insufficiency. Cardiac examination,
including echocardiography was normal.
2.2. Development, cognition and psychiatric history
I.1 does not have any psychiatric history or psychological
problems in the past or present. His psychomotor development
was normal and his IQ could be estimated at a low average level.
His youngest son II.3 has about the same intellectual and psy-
chological profile with a low average IQ and no psychiatric history
(Table 1).
In contrast, patient II.1 had been institutionalized in a residential
setting for people with moderate to severe intellectual disabilities
after several hospitalizations in psychiatric wards because of
behavioral problems such as running away and aggressive attacks.
During early childhood, a moderate to severe delay of motor skills,
speech and cognition was noticed. In 2004 at age 33, psychomotor
testing showed a basic motor age of 2 years and an effective motor
age of 3 years 8 months. McCarthy development scales revealed a
verbal level of 5 years 3 months, a performance level of 5 years, a
quantitative level of 6 years 9months, general cognition at 5 years 3
months and memory at 5 years 6 months. Language assessment
with the Reynell developmental language test (RDLT) revealed a
language level of 3 years 9 months on the comprehension scale, 4
years on the expressive scale and 3 years and 9 months on the total
language scale. At the time of diagnosis of 22q11 DS at age 39, he
had been living in the residential care for people with a severe ID
for about 6 years. He had been diagnosed with autism spectrum
disorder (ASD) in the past. At age 28 his full scale IQ (FSIQ) was
estimated at 35. At age 43 neurocognitive testing revealed a verbal
level of 5 years 3 months, a performance level of 4 years 4 months
and a total level of 4 years 7 months. Caregivers needed an adapted
way to communicate with him and handle his behavioral problems.
It took several years before the aggressive attacks and running
away diminished. Although the use of physical restraints was at
times still necessary, caregivers noted that he was more at ease.
III.1 presented with a moderate developmental delay both on
motor and on verbal development with start of walking at 23
months, slow and indistinct speech, and difficulties with toilet
training. At the age of 3, 5 years, Peabody developmental motor
scales (PDMS) showed a gross motor quotient of 70 and a fine
motor quotient of 58, both scoring below the 1st percentile for her
age. Reynell Developmental Language Scales revealed scores below
the 1st percentile for her age on the two subscales and the totalgree with paternal transmission of the 22q11.2 deletion syndrome:
s (2015), http://dx.doi.org/10.1016/j.ejmg.2015.01.008
Fig. 2. Pictures of the 4 individuals with a 22q11.2DS. Arrows are used to identify each individual.
Table 1
Overview of the characteristics in the affected individuals. Q4
I.1 II.1 II.2 III.1
AGE 66y 43y 35y 7y
Age at diagnosis 63y 39y 31y 3y
Diagnostic Tool FISH CGH-array FISH FISH
Medical history:
Cardiopathy RAA Septal defect TOF þ RAA None
Inflammatory diseases Psoriatic arthritis None None Recurrent bronchopneumonia
Hematology Thrombocytopenia (mild) Thrombocytopenia (mild) None None
Speech and palate function Normal Studder Normal Verbal developmental dyspraxia
Body features Very mild facial features Mild scoliosis
Overcorrected clubfeet
Mild facial features Plagiocephaly
Pronounced
Nosebridge
Deep-set eyes
Small ears
Small mouth
Short philtrum
Pointed fingers
Development, cognition and psychiatric history:
Motor skills e Start walking at 19 months e Start walking at 23 months
BMA ¼ 2y GMQ < 1st pctl
EMA ¼ 3y 8m FMQ < 1st pctl
Language and speech e At age 33y e Slow speech development
CLS ¼ 3y 9m CLS < 1st pctl
ELS ¼ 4y ELS < 1st pctl
TLS ¼ 3y 9m TLS < 1st pctl
Psychiatric diagnoses None - Behavioral problems with
oppositional behavior
- Impulse control disorder,
unspecified
- ASD diagnosis
None ADHD
IQ Low average Severe ID Low average Mild-moderate ID
FSIQ  35 at age 28 FSIQ  59 at age 5
Social and occupational functioning:
Social þ Very limited þ þ
Work Retirement Residential care Full time job /
Abbreviations: RAA ¼ right aortic arch; TOF ¼ Tetralogy of Fallot; BMA ¼ basic motor age; EMA ¼ effective motor age; GMQ ¼ gross motor quotient; FMQ ¼ fine motor
quotient; CLS ¼ comprehensive language score on the Reynell Developmental Language Scales (RDLS); ELS ¼ Expressive Scale score on RDLS; TLS ¼ total scale score on RDLS;
ASD ¼ autism spectrum disorder; ADHD ¼ attention deficit and hyperactivity disorder; ID ¼ intellectual disability; FSIQ ¼ Full Scale Intelligence Quotient.
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(Groningse Ontwikkelingsschaal), a Dutch adaptation of the Kauf-
man Assessment Battery for Children, FSIQ was estimated at 59 at
age 5 years. After trying the first year of preschool, she changed to a
school with a special needs education program and an intensive
revalidation/rehabilitation program was started for the specific
developmental delays and deficits.
2.3. Adaptive and social functioning
Comparing the levels of social and occupational functioning
between the four family members, we noticed that the grandfather
I.1 had a good social and occupational functioning. He was able to
work until his retirement, was married, raised his two sons andwas
able to handle the challenges with his oldest son (II.1).
Patient II.3, despite his severe cardiac disorder, had a good level
of social and occupational functioning. He was able to finish voca-
tional school, find a job and start a family. Heworks as a truck driver
and spends most of his time on the road driving through foreign
countries, depends on himself to solve encountered problems.
In contrast, his older brother II.1 carrying the same deletion,
grew up in the same family but has been living institutionalized for
more than two decades; first in a psychiatric setting and afterwards
in a residence with specialized care for individuals with a severe
intellectual disabilities. He needs help 24 h a day, 7 days aweek and
is always accompanied by a caregiver when going out. Because
social interactions were very stressful and evoked behavioral
problems, visits were limited to his nearest family once a week.
Organized events were not shared with him beforehand because
the anticipation made him high strung and caused physical com-
plaints and behavioral problems. II.1 lives in a day to day world that
is organized by his caregivers.
The youngest family member III.1 has been able to gain a
moderate level of functioning with the support of a specialized
educational program, an adapted school environment and medi-
cation for ADHD.
3. Discussion
This report describes a pronounced clinical variability in a 3
generation familial 22q11.2 deletion with paternal transmission.
Although it has been described that the prevalence of males with a
paternal transmission of the 22q11.2 deletion is much lower than
maternal transmission [Thomas et al., 2006; Torres-Juan et al.,
2007], the phenotypic expression and the clinical variability seem
to be comparable to the known high phenotypic variability in the
total 22q11.2DS population [Cirillo et al., 2014; Digilio et al., 2003].
An aggravation of the phenotype over the three generations is
observed for developmental delay, speech delay, IQ and facial fea-
tures but not for immune dysfunction or congenital heart defects,
contrasting with the findings of Cirillo et al. [2014]. If looking only at
the first and second generation we observe an aggravation of the
cardiac phenotype with I.1 only having a right aortic arch while
both of his sons II.1 and II.3 were diagnosed with a cardiac
malformation, respectively a septal defect and a Tetralogy of Fallot.
On the other hand, going from second to third generation this
pattern does not continue with III.3 having no cardiac features of
22q11.2 DS. We can speculate that the aggravation noted in earlier
studies could be in part biased by the diagnostic process in which
the second generation most of the time is the person first to be
diagnosed because of the clinical presentation, and the first
generation parents are most of the time diagnosed through
screening afterwards. In most cases, the cardiac phenotype seems
to be the reason for referral to genetic counseling, especially in
infancy before the age of 2 years [Cancrini et al., 2014; OskarsdottirPlease cite this article in press as: Vergaelen E, et al., 3 generation pedi
Intrafamilial phenotypic variability, European Journal of Medical Geneticet al., 2005]. Another contributing factor could be that a more
severe phenotype seems to cause a stronger negative selective
pressure, both because of biological and sociological disadvantages.
In the older generations of 22q11.2 DS patients, the presence of a
severe CHD caused a negative selection. In the past, severe CHD or
immunodeficiency had higher mortality rates. Renewed cardiac
surgical procedures and stem cell transplantation have lowered the
mortality rates and it no longer seems to be an important factor in
reduced reproductive fitness. However it has been shown recently
that certain neuropsychiatric phenotypes and intellectual
disabilities were significant negative predictors of reproductive
fitness [Costain et al., 2011]. Also a different impact was found
between the two sexes with a lower reproductive fitness in men
compared to women [Costain et al., 2011].
Several mechanisms could be responsible for the pronounced
clinical variability in this three generation family and the presence
of an increasing complexity and severity of the symptoms in sub-
sequent/consecutive generations within this limited pool of genetic
information. With regard to the intellectual disability in the third
generation (III.1), an aggravation seems to be present compared to
second (II.3) and first generation (I.1). Current findings indicate that
the genetic architecture of intellectual disability is complex and a
wide variability in intelligence has been found in the 22q11.2DS
population ranging from normal intelligence to moderate-severe
intellectual disability. They have found a lower IQ in familial
compared to de novo deletions [De Smedt et al., 2007]. Proposed
explanations were a lower educational attainment level of the
parents of children with familial inherited deletions, and
assortative mating, resulting in a lower educational level in the
unaffected parent. Studies also have found a role for the genetic
variation within the 22q11.2 region [Gothelf et al., 2005], for
environmental factors such as socioeconomic status [Shashi et al.,
2010] but also parental IQ and siblings IQ [Olszewski et al., 2014].
Additionally several factors contributing to the variability in IQ
(possibly playing a role in the variability and aggravation within
this family) have not yet been systematically studied. To explain
this variability future studies should look at the role of assortative
mating and the genetic background, but also investigate the role
of other environmental factors such as social support, therapy
and coping strategies [Swillen & McDonald-McGinn, submitted].
Looking at the phenotypic variability within this family the
difference between the 2 s generation brothers (II.1 and II.3) is
notable. The intellectual disability and behavioral problems of II.1
seem to be more severe than expected in a 22q11.2 DS and are in
contrast with the lack of neuropsychiatric problems and intellec-
tual disability in the younger brother (II.3). A more severe or
complex clinical presentation (such as a severe intellectual
disability or severe developmental delay) could be explained by a
so called second hit. In broad terms, a second hit could be defined as
a genetic, epigenetic or environmental insult that has an important
influence on the phenotypic expression. Studies have shown that a
more severe or complex clinical presentation is associated with a
higher prevalence of additional large copy number variations
(CNV’s) [Kumar, 2010; Girirajan et al., 2012]. The presence of two
large CNV’s of unknown clinical significance was associated with
an eight times increased presence of a developmental delay
[Girirajan et al., 2012]. Within a population of pediatric cases
with a 16p12.1 microdeletion the presence of a second large CNV
was associated with an additional or more severe phenotypes
compared to the classical phenotype [Girirajan et al., 2010].
However, in subject II.2 no other relevant CNV could be detected
by the 105k array CGH. This observation is in line with the study
from Bassett et al. [2008] that found no evidence for a general
increase of de novo CNVs in 22q11.2DS in a cohort of 100 adults
with 22q11.2DS compared with controls [Bassett et al., 2008].gree with paternal transmission of the 22q11.2 deletion syndrome:
s (2015), http://dx.doi.org/10.1016/j.ejmg.2015.01.008
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already been linked to the 22q11.2DS in the literature. Two ex-
ceptions are the psoriatic arthritis in I.1 and the triphalangeal
thumb of III.1 for which we couldn’t find a direct association with
the presence of a 22q11.2 deletion in the literature. In our center we
have at least one other patient with a 22q11.2DS, that had a tri-
phalangeal thumb. It could be that this is a less frequent but
important clinical feature of the 22q11.2 DS. The psoriatic arthritis
falls in line with the literature that describes the presence of an
auto-immune disease, including the full range of possibilities, in 8e
10% of the 22q11.2 DS patients [Lima et al., 2011].
In this family the neuropsychiatric phenotype and intellectual
disability are associated with a lower level of social and occupa-
tional functioning while a congenital heart disease does not. In
adults with 22q11.2 DS a correlation was found between IQ and
adaptive functioning skills, with IQ as a significant predictor of
functional impairment. Congenital heart disease and history of
mood/anxiety disorders were not significant predictors of func-
tioning [Butcher et al., 2012]. In children and adolescents, the
relationship between IQ and adaptive functioning remains
unclear with different studies giving conflicting results
[Angkustsiri et al., 2012; Dewulf et al., 2013].
In conclusion, a pronounced variability in phenotypic expres-
sion was found in this three generation 22q11.2deletion family.
There are arguments that suggest that the phenotype gets more
severe and complex in second and third generation, with an
aggravation of the neuropsychiatric phenotype giving a lower IQ,
psychiatric symptoms and behavioral problems. Cardiac or other
somatic phenotypes do not seem to aggravate but there is a pro-
nounced intrafamilial variability. We can assume that several
mechanisms play an important role in this heterogeneity and part
of the answer should be found in the genetic background under-
lying the 22q11.2 deletion. Hopefully further research comparing
this genetic background in large groups of 22q11.2DS patients
focusing on the presence or absence of specific clinical character-
istics could identify the genetic causes of this variation. It is
important to not only focus on the clinical variability of this syn-
drome but also on the impact of level intellectual and adaptive
functioning. As a consequence of this variability, all individual
family members are differently affected in social, occupational and
adaptive functioning and therefore need a personalized care. This
report emphasizes the need for a multidisciplinary approach for
this population taking into account the individual needs. It stresses
the importance of a good standardized baseline examination, but
also regular follow-ups to adapt the care to the changing needs of
the patients.
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